Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: Impact of inappropriate doses (the EMIR study)

  1. Fernández, M.S.
  2. Marín, F.
  3. Rafols, C.
  4. Arribas, F.
  5. Barrios, V.
  6. Cosín-Sales, J.
  7. Sánchez, M.A.
Aldizkaria:
Journal of Comparative Effectiveness Research

ISSN: 2042-6313,  2042-6305

Argitalpen urtea: 2021

Alea: 10

Zenbakia: 7

Orrialdeak: 583-593

Mota: Artikulua

DOI: 10.2217/CER-2020-0286 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus